Hamilton Health Sciences – Renaissance in cancer research
Hamilton Health Sciences (HHS) features some of CDCR's scientists and associate members in an article about HHS' vision for a "renaissance" in cancer research in HHS and Hamilton. Driving this vision is a plan to improve collaboration between basic researchers, clinical trial researchers, clinician scientists and hospital clinicians for exploring and developing new treatment options for patients. The members include CDCR Director Dr. Sheila Singh, Dr. Tobias Berg, Associate Members Dr. Rosalyn Juergens and Dr. Aly-Khan Lalani.
Read more at Hamilton Health Sciences.
News